OpenAlex
PricingAboutJobs
Log inGet started
Work

Abstract 16873: Safety and Efficacy of Alirocumab in Patients With Atherosclerotic Cardiovascular Disease, Based on Statin Intensity: Pooled Analyses of 5 Placebo-controlled Phase 3 Trials

HTML

Year: 2016
Type: conference-abstract
Source: Circulation
Authors: Christie M. Ballantyne, Peter A. McCullough, Santosh K. Sanganalmath, Andrew Koren, Alexia Letierce, Michael H. Davidson
Institutions: Houston Methodist, Baylor College of Medicine, Baylor University Medical Center, Baylor Jack and Jane Hamilton Heart and Vascular Hospital, Regeneron (United States), Sanofi (United States), Sanofi (France), University of Chicago, University of Chicago Medical Center
Language: English

Topic: Lipoproteins and Cardiovascular Health
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Keywords: alirocumab, PCSK9 inhibitors, atherosclerotic cardiovascular disease, statin intensity, LDL cholesterol lowering, treatment-emergent adverse events, lipid-lowering therapy, coronary artery disease, stroke, peripheral arterial disease
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2786107694
Cites:
Cited by:
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security